Business PerformanceACI’s strength in pharmaceutical and e-commerce sales, combined with its ability to further leverage its massive customer loyalty program, will continue to drive accelerating Business Performance trends.
Growth InitiativesACI will continue to drive growth through the ongoing investment of its cash flow in key growth initiatives, including enhanced digital and omnichannel capabilities combined with new store openings and upgrades, as well as enhancing shareholder returns through ongoing dividend increases and share repurchases.
ValuationACI is considered the cheapest stock in coverage and may see valuation expansion as investors seek defensive stocks.